Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
Abroad (travel likely)RecruitingPHASE1
Conditions
Ewing Sarcoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Cedars Sinai Medical Center, Los Angeles, California, United States
University of California Los Angeles, Los Angeles, California, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Chris OBrien Lifehouse, Camperdown, New South Wales, Australia
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Perth Childrens Hospital, Nedlands, Western Australia, Australia
Study leads
MD
Study Director
Amgen